FSFernanda Maria Araújo de Souza

Fernanda Maria Araújo de Souza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fernanda Maria Araújo de Souza has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Multidimensional Impact of COVID-19 and Post-COVID-19 Conditions on Sexual and Reproductive Health: A Systematic Review

    by Mércia Thaisa Araújo Costa Homero, Elaine dos Santos Farias, Fernanda de Souza Silva, Domenico Lopes, Sarah Alves de Assis, Iasmim Isaires Neri dos Santos, Igor Santana de Melo, Fernanda Maria Araujo de Souza, Olagide Wagner de Castro

    Coronavirus disease 2019 (COVID-19) has been associated with sexual and reproductive disturbances, but whether these findings reflect transient systemic illness or persistent dysfunction remains uncertain. We systematically searched PubMed, Scopus, Web of Science, Virtual Health Library, World Health Organization Global Index Medicus, and Embase for human studies published from 2020 through 2025, supplemented by ResearchRabbit citation- and similarity-based screening; the final update was performed in June 2026. Eligible studies assessed sexual, reproductive, psychological/behavioral, or biological outcomes in individuals with acute or post-COVID-19 conditions. Three reviewers independently extracted and verified data, using design-specific National Institutes of Health, Joanna Briggs Institute, and Mendelian-randomization-specific frameworks to assess risk of bias. Because of substantial clinical and methodological heterogeneity, results were synthesized narratively. The final synthesis included 218 eligible reports, corresponding to 214 conservative study/cohort units after confirmed companion/derived-publication linkage. Erectile dysfunction was the most consistent sexual outcome, whereas reproductive studies mainly reported reduced semen quality and alterations in testosterone and gonadal-axis markers, often appearing short-term. Inflammatory, oxidative, endocrine, vascular, histopathological, molecular, and psychosocial findings supported a multidimensional framework. However, the evidence was predominantly male-focused, observational, and heterogeneous, limiting causal and long-term inference. COVID-19 may affect sexual and reproductive health through interacting biological and psychosocial pathways, but persistent infertility or definitive reproductive impairment remains unconfirmed. The protocol was not registered; no specific external funding was received.

  • Ontogenic, Immunological, and Behavioral Changes of Crack Cocaine Exposure During the Gestational Period

    by Yngrid Mickaelli Oliveira dos Santos, Igor Santana-Melo, Amanda Larissa Dias Pacheco, Milenna Maria Jatoba Hasten Reiter, Maisa de Araújo Costa, Keyla Silva Nobre Pires, Fernanda Maria Araújo de Souza, Jucilene Freitas-Santos, Mayara Rodrigues Barbosa, Jeferson Santana Ursulino, et al.

    Crack cocaine has a high addictive power that stimulates the central nervous system (CNS), and its high consumption by women of reproductive age has generated many challenges for public health. Crack cocaine use by pregnant women has been correlated with CNS malformations, cell damage, and changes in the immune system. Our purpose was to evaluate the effects of gestational exposure to crack cocaine in pregnant rats on ectoplacental cone cells, immune organs, maternal behavior, anxiety-like phenotype, metabolites, and sensorimotor reflex development of offspring. Pregnant rats were exposed to air or crack cocaine (200 mg) from the 5th gestational day (5thGD) to the 9th GD or until the end of pregnancy. Our findings showed that gestational exposure to crack cocaine increased trophoblast cell death, associated with reduced ectoplacental cone outgrowth in vitro. Furthermore, anxiogenic-like behavior in pregnant rats and negligence in maternal care were observed after exposure to crack cocaine. The development of motor reflexes in the offspring remained unchanged. In addition, exposure to crack cocaine during pregnancy reduced the relative weight of the spleen and CD8 + T lymphocyte subsets. No changes were observed in the thymus. Finally, we observed a series of changes in the metabolites of lactating rats exposed to crack cocaine during pregnancy. Taken together, our findings provide new insight into gestational changes promoted following exposure to crack cocaine and support future clinical interventions and treatments.


  • N-Formyl-Methionyl-Leucyl-Phenylalanine Plays a Neuroprotective and Anticonvulsant Role in Status Epilepticus Model

    by Igor Santana de Melo, Robinson Sabino-Silva, Maisa Araújo Costa, Emília Rezende Vaz, Cassius Iury Anselmo-E-Silva, Thainá de Paula Soares Mendonça, Kellysson Bruno Oliveira, Fernanda Maria Araújo de Souza, Yngrid Mickaelli Oliveira dos Santos, Amanda Larissa Dias Pacheco, et al.

    Status epilepticus (SE) is described as continuous and self-sustaining seizures, which triggers hippocampal neurodegeneration, inflammation, and gliosis. N-formyl peptide receptor (FPR) has been associated with inflammatory process. N-formyl-methionyl-leucyl-phenylalanine (fMLP) peptide plays an anti-inflammatory role, mediated by the activation of G-protein-coupled FPR. Here, we evaluated the influence of fMLP peptides on the behavior of limbic seizures, memory consolidation, and hippocampal neurodegeneration process. Male Wistar rats (Rattus norvegicus) received microinjections of pilocarpine in hippocampus (H-PILO, 1.2 mg/μL, 1 μL) followed by fMLP (1 mg/mL, 1 μL) or vehicle (VEH, saline 0.9%, 1 μL). During the 90 min of SE, epileptic seizures were analyzed according to the Racine’s Scale. After 24 h of SE, memory impairment was assessed by the inhibitory avoidance test and the neurodegeneration process was evaluated in hippocampal areas. There was no change in latency and number of wet dog shake (WDS) after administration of fMLP. However, our results showed that the intrahippocampal infusion of fMLP reduced the severity of seizures, as well as the number of limbic seizures. In addition, fMLP infusion protected memory dysfunction followed by SE. Finally, the intrahippocampal administration of fMLP attenuated the process of neurodegeneration in both hippocampi. Taken together, our data suggest a new insight into the functional role of fMLP peptides, with important implications for their potential use as a therapeutic agent for the treatment of brain disorders, such as epilepsy. Graphical Abstract Schematic drawing on the neuroprotective and anticonvulsant role of fMLP during status epilepticus. Initially, a cannula was implanted in hippocampus and pilocarpine/saline was administered into the hippocampus followed by fMLP/saline (A-C). fMLP reduced seizure severity and neuronal death in the hippocampus, as well as protecting against memory deficit (D).